Insulin resistance and endothelin: another pathway for renal injury in patients with the cardiometabolic syndrome?
about
Endothelin, hypertension and chronic kidney disease: new insights.Chronic kidney disease among overweight and obesity with and without metabolic syndrome in an urban Chinese cohort.Association of cardiac NT pro-β-type natriuretic peptide with metabolic and endothelial risk factors in young obese hypertensive patients: a perspective on the hypothalamic pituitary adrenal axis activation.PPAR-γ agonism for cardiovascular and renal protection.Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease.Longitudinal relationships of metabolic syndrome and obesity with kidney function: Healthy Twin Study.
P2860
Insulin resistance and endothelin: another pathway for renal injury in patients with the cardiometabolic syndrome?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Insulin resistance and endothe ...... the cardiometabolic syndrome?
@en
Insulin resistance and endothe ...... the cardiometabolic syndrome?
@nl
type
label
Insulin resistance and endothe ...... the cardiometabolic syndrome?
@en
Insulin resistance and endothe ...... the cardiometabolic syndrome?
@nl
prefLabel
Insulin resistance and endothe ...... the cardiometabolic syndrome?
@en
Insulin resistance and endothe ...... the cardiometabolic syndrome?
@nl
P2860
P1476
Insulin resistance and endothe ...... the cardiometabolic syndrome?
@en
P2093
Anastasios N Lasaridis
Pantelis A Sarafidis
P2860
P304
P356
10.1111/J.1559-4572.2008.00009.X
P577
2008-01-01T00:00:00Z